Dr. Tawfik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UNM Comprehensive Cancer Center Msc07 4025
Albuquerque, NM 87131Phone+1 505-272-4946Fax+1 505-925-0100
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2011 - 2014
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2011
Certifications & Licensure
- NM State Medical License 2018 - 2025
- TX State Medical License 2015 - 2019
- NC State Medical License 2011 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsPhase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.Jennifer A Chan, Susan Geyer, Tyler Zemla, Michael V Knopp, Spencer Behr
The New England Journal of Medicine. 2025-02-13 - A Melanoma Brain Metastasis CTC Signature and CTC:B-cell Clusters Associate with Secondary Liver Metastasis: A Melanoma Brain-Liver Metastasis Axis.Tetiana Y Bowley, Mireya C Ortiz, Irina V Lagutina, Mara P Steinkamp, Bridget N Fahy
Cancer Research Communications. 2025-02-01 - A Remotely Delivered Light-Intensity Physical Activity Intervention for Older Cancer Survivors: Protocol for a Feasibility Randomized Controlled Trial.Cindy K Blair, Ursa Brown-Glaberman, Scott T Walters, Claire Pestak, Tawny Boyce
JMIR Research Protocols. 2024-12-13
Press Mentions
- The University of New Mexico Comprehensive Cancer Center Receives Three-Year Reaccreditation from the Commission on CancerOctober 29th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: